Key facts
- It has raised $25.0M; the latest was Early Stage VC ($21.0M) in Dec 2024.
- Notable investors include Creative Destruction Lab, Google for Startups, MassChallenge, Drive Capital, Verissimo Ventures — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Droxi
- ·The full record, as it builds
Funding rounds
No funding rounds for Droxi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Droxi
Developer of a clinical workflow platform designed to streamline and automate administrative tasks. The company's platform uses artificial intelligence to offer prescription management, inbox message management, and lab results automation and integrates with electronic health record systems, enabling healthcare providers to save time, reduce administrative overhead, and improve efficiency.
- Sector
- Healthcare
- HQ
- Youngstown, OH, United States
- Founded
- 2021
- Employees
- 59
- Website
- droxi.ai/
- Ownership
- Privately Held (backing)
Droxi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Droxi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Droxi in its N-PORT filings yet. We sweep new filings monthly.